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Abstract
Background: Vitamin B12 deficiency is associated with a wide spectrum of  neuro-psychiatric manifestations.
Results: We report a case of  a 44 year old female patient referred to the haematology unit with vitamin B12
deficiency presenting as an acute confusional state or delirium. Total resolution of  the psychiatric symptoms
occurred following parenteral vitamin B12 replacement therapy.
Conclusion: This case report highlights one of the neuro-psychiatric presentations of vitamin B12 deficiency
in a previously healthy individual.
Key words: Vitamin B12 deficiency, acute confusional state, delirium.




College of Health Sciences, Makerere University
P.O. Box 7062 Kampala, Uganda
Tel: 256 414 541188
Mobile: +256 782 393955
E-mail: davouirek@yahoo.co.uk.
Introduction
Vitamin B12 deficiency has been highly linked to
several psychiatric disorders like impaired memory,
ir ritability, depression, dementia, delirium,
schizophrenia and psychosis1. Other commonly
associated neurological disorders include
paraesthesias, numbness and sub acute combined
degeneration of the spinal cord2.
Varying prevalence of  vitamin B12 deficiency has
been reported among patients with different
psychiatric conditions. Published studies have
documented prevalence of 29%, 44% and 70.8%
among patients with primary dementia3, depression4
and schizophrenia5 respectively.
In Africa, Maktouf et al in a multi centre prospective
study in Tunisia found a prevalence of  vitamin B12
deficiency of 14% among 82 psychiatric patients6.
A recent study done in Uganda demonstrated
prevalence of low vitamin B12 levels of 28.6%
among 280 psychiatric patients admitted at the main
psychiatric referral hospital7. One percent of these
patients had delirium as the primary psychiatric
diagnosis.
Case report
A 44 year old HIV sero negative lady was referred
to the haematology unit from a rural hospital mainly
for blood transfusion due to severe anemia. She
presented with a three weeks history of
uncoordinated speech, aggressiveness, reduced sleep,
wandering away from her home, poor concentration
and visual hallucinations mainly worsening at night.
The above symptoms were preceded by a three
months history of generalised body weakness,
intense paraesthesias of the lower limbs, palpitations
and exertional dyspnea.
She did not have any past psychiatric history,
history suggestive of  diabetes mellitus, auto immune
diseases or any past gastric or ileal surgery. She was a
peasant farmer residing about 600 kilometres from
the hospital and was not a vegetarian. Her daily diet
was predominantly carbohydrate rich with minimal
intake of animal protein.
Physical examination revealed severe pallor
of the mucous membranes and atrophic tongue
papillae. She was fully awake but disoriented in time
and place, looked sad with poor concentration,
incoherent speech and short term memory
impairment. Neurological examination revealed
diminished tendon reflexes globally and impaired
position and vibration sense of the first
metatarsophalangeal joint bilaterally. Haematological
tests included a complete blood count (CBC) which
showed severe anemia of  5g/dl (normal: 12-16) with
a raised mean cell volume of  119 (normal: 80-100),
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thrombocytopenia of  137,000 (normal: 150,000 -
400,000) and normal white blood cell count. The
peripheral film examination showed macrocytes with
polychromasia. Serum vitamin B12 levels were very
low at 62.94pg/ml (normal: 204-946). Cerebrospinal
fluid examination, liver and renal function tests were
all normal. Red blood cell folate levels and antibodies
to the intrinsic factor were not done due to financial
constraints.
A diagnosis of delirium or acute confusional
state secondary to vitamin B12 deficiency probably
due to inadequate dietary intake was made. The
patient was started on intramuscular vitamin B12 1
mg daily for one week which was followed by 1
mg monthly with oral iron and folate therapy for a
week. She was also transfused with two units of
whole blood. There was complete resolution of the
symptoms and improvement in the CBC indices
within one week of administration of the vitamin
B12 while on the ward. The patient was fully
counselled about her condition and discharged later.
Discussion
This case report illustrates an acute confusional state
or delirium as a manifestation of vitamin B12
deficiency. Such psychiatric conditions can be the
solitary or preliminary manifestations of vitamin B12
deficiency and may precede haematological signs by
several months or years8.
A serum vitamin B12 level of less than 200 pg/ml is
diagnostic of vitamin B12 deficiency9 as shown in
the patient discussed. However, measuring serum
levels of methylmalonic acid (MMA) or total
homocysteine have also been found to be more
sensitive biochemical indicators of vitamin B12
deficiency especially among people with trivial or
no haematological abnormalities10.
Several mechanisms have been described to explain
neuro cognitive dysfunction due to vitamin B12
deficiency. Vitamin B12 is essential in the synthesis
of monoamines like serotonin and dopamine11. It is
also very integral in the methylation process of
homocysteine to methionine which is activated into
S-adenosyl-methionine that donates its methyl group
to methyl acceptors such as myelin, neurotransmitters
and membrane phospholipids12. Metabolically
significant vitamin B12 deficiency results in disruption
of the methylation process and intracellular
accumulation of homocysteine that is potentially toxic
to neurones11-12.
The most common cause of vitamin B12 deficiency
is insufficient dietary intake especially among
alcoholics and vegetarians. Other causes include
atrophic gastritis, mainly in the elderly, pernicious
anemia, malabsorption syndromes; and drug
induced (e.g. metformin and proton pump inhibitors
(PPIs))2, 8.
Clinical evaluation of patients with vitamin B12
deficiency should include a thorough drug history,
assessment for malabsorption syndromes, and
screening for autoimmune causes of vitamin B12
deficiency, such as pernicious anemia.  Much of  this
information can be gathered based on clinical history
and physical exam8. In resource limited settings,
obtaining ancillary testing (e.g. anti-parietal cell and
anti-intrinsic factor antibodies) may be a challenge
due to high test costs or lack of  availability of  tests.
The presumed cause of vitamin B12
deficiency in this patient was inadequate dietary intake
of Vitamin B12 rich foods which is very common
among people living in the rural areas of Uganda.
She also did not have any history of chronic PPI or
metformin use or any clinical evidence suggestive
of auto immune conditions and malabsorption
syndrome.
Both parenteral and oral vitamin B12 replacement
therapies have been demonstrated to have equivalent
effectiveness in achieving the desirable haematological
and neurological remissions regardless of the
aetiology of  vitamin B12 deficiency13-15. Intra
muscular vitamin B12 treatment was preferred in
this patient because it is cheaper in Uganda and also
to improve on compliance.
Conclusion
This case report describes a previously healthy lady
without past personal psychiatric history presenting
with delirium secondary to vitamin B12 deficiency.
It illustrates the importance of considering the
possibility of vitamin B12 deficiency among patients
with delirium and other psychiatric symptoms. Serum
vitamin B12 determination in these patients should
be encouraged as part of standard clinical evaluation.
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